MedTrace Logo

A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients

NCT05486091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-08-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the feasibility of integrating Brief Cognitive-Behavioral Therapy (BCBT) counseling with a software application (app) to prevent future suicidal thoughts and behaviors.

Conditions

  • Suicidal and Self-injurious Behavior

Interventions

BEHAVIORAL

App-Enhanced Brief Cognitive-Behavioral Therapy

BCBT is a cognitive-behavioral intervention designed to target core skills deficits among suicidal individuals. App-enhanced BCBT incorporates the use of a SmartPhone app during the therapy sessions.

Sponsors & Collaborators

  • Oui Therapeutics, Inc.

    collaborator INDUSTRY

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Gretchen Diefenbach, PhD · Anxiety Disorders Center, Institute of Living

  • David Tolin, PhD · Anxiety Disorders Center, Institute of Living

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2023-02-15
Completion
2023-02-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05486091 on ClinicalTrials.gov